HLA-A2-restricted peripheral blood cytolytic T lymphocyte response to HPV type 16 proteins E6 and E7 from patients with neoplastic cervical lesions

Cancer Immunology Immunotherapy

Volumn 42, Issue 3, 1996, Pages 151-160

  Evans, Carys ^a   Bauer, Stefan ^c   Grubert, Thomas ^b   Brucker, Cosima ^b   Baur, Sigfried ^a,b   Heeg, Klaus ^a   Wagner, Hermann ^a   Lipford, Grayson B ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c NONE

Author keywords

CaSki cell line; cervical intraepithelial neoplasia; cytolytic T cell; HLA A2; human papillomavirus type 16

Indexed keywords

HLA A2 ANTIGEN; VIRUS PROTEIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; PAPILLOMA VIRUS; PRIORITY JOURNAL; TUMOR CELL LINE; UTERINE CERVIX CARCINOMA;

EID: 0029878889     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050265     Document Type: Article

References (48)

1. Altmann A, Jochmus Kudielka I, Frank R, Gausepohl H, Moebius U, Gissmann L, Meuer SC (1992) Definition of immunogenic determinants of the human papillomavirus type 16 nucleoprotein E7. Eur J Cancer 28:326-333
2. Baker CC, Phelps WC, Lindgren V, Braun MJ, Gonda MA, Howley PM (1987) Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol 61:962-971
3. Band V, Dalal S, Delmolino L, Androphy EJ (1993) Enhanced degradation of p53 protein in HPV-6 and BPV-1 E6-immortalized human mammary epithelial cells. EMBO J 12:1847-1852
4. Bauer S, Heeg K, Wagner H, Lipford GB (1995) Identification of H-2Kb binding and immunogenic peptides from human papillomavirus tumour antigens E6 and E7. Scand J Immunol 42:317-323
5. Chen L, Mizuno MT, Singhal MC, Hu SL, Galloway DA, Hellstrom I, Hellstrom KE (1992) Induction of cytotoxic T lymphocytes specific for a syngeneic tumor expressing the E6 oncoprotein of human papillomavirus type 16. J Immunol 148:2617-2621
6. Chen LP, Thomas EK, Hu SL, Hellstrom I, Hellstrom KE (1991) Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen. Proc Natl Acad Sci USA 88:110-114
7. De Villiers EM (1989) Heterogeneity of the human papillomavirus group. J Virol 63:4898-4903
8. Dietl JA, Horny HP, Buchholz F (1991) Lymphoreticular cells in invasive carcinoma of the uterine cervix: an immunohistological study. Int J Gynaecol Obstet 34:179-182
9. Dillner J, Dillner L, Robb J, Willems J, Jones I, Lancaster W, Smith R, Lerner R (1989) A synthetic peptide defines a serologic IgA response to a human papillomavirus-encoded nuclear antigen expressed in virus-carrying cervical neoplasia. Proc Natl Acad Sci USA 86:3838-3841
10. Feltkamp MC, Smits HL, Vierboom MP, Minnaar RP, Jongh BM de, Drijfhout JW, Schegget J ter, Melief CJ, Kast WM (1993) Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur J Immunol 23:2242-2249
11. Ferguson A, Moore M, Fox H (1985) Expression of MHC products and leucocyte differentiation antigens in gynaecological neoplasms: an immunohistological analysis of the tumour cells and infiltrating leucocytes. Br J Cancer 52:551-563
12. Ghosh AK, Moore M (1992) Tumour-infiltrating lymphocytes in cervical carcinoma. Eur J Cancer 28A:1910-1916
13. Halpert R, Fruchter RG, Sedlis A, Butt K, Boyce JG, Sillman FH (1986) Human papillomavirus and lower genital neoplasia in renal transplant patients. Obstet Gynecol 68:251-258
14. Hilders CG, Ras L, van Eendenburg JD, Nooyen Y, Fleuren GJ (1994) Isolation and characterization of tumor-infiltrating lymphocytes from cervical carcinoma. Int J Cancer 57:805-813
15. Ho GY, Burk RD, Fleming I, Klein RS (1994) Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression. Int J Cancer 56:788-792
16. Jenison SA, Firzlaff JM, Langenberg A, Galloway DA (1988) Identification of immunoreactive antigens of human papillomavirus type 6b by using Escherichia coli-expressed fusion proteins. J Virol 62:2115-2123
17. Jochmus Kudielka I, Schneider A, Braun R, Kimmig R, Koldovsky U, Schneweis KE, Seedorf K, Gissmann L (1989) Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. J Natl Cancer Inst 81:1698-1704
18. Kadish AS, Romney SL, Ledwidge R, Tindle R, Fernando GJ, Zee SY, Van Ranst MA, Burk RD (1994) Cell-mediated immune responses to E7 peptides of human papillomavirus (HPV) type 16 are dependent on the HPV type infecting the cervix whereas serological reactivity is not type-specific. J Gen Virol 75:2277-2284
19. Kast WM, Brandt RM, Sidney J, Drijfhout JW, Kubo RT, Grey HM, Melief CJ, Sette A (1994) Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. J Immunol 152:3904-3912
20. Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, DeRouen TA, Galloway DA, Vernon D, Kiviat NB (1992) A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 327:1272-1278
21. Lanzavecchia A (1993) Identifying strategies for immune intervention. Science 260:937-944
22. Lipford GB, Hoffman M, Wagner H, Heeg K (1993) Primary in vivo responses to ovalbumin. Probing the predictive value of the Kb binding motif. J Immunol 150:1212-1222
23. Lipford GB, Bauer S, Wagner H, Heeg K (1995) Peptide engineering allows cytotoxic T-cell vaccination against human papilloma virus tumour antigen, E6. Immunology 84:298-303
24. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ (1992) Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 79:328-337
25. Morrison EA, Ho GY, Vermund SH, Goldberg GL, Kadish AS, Kelley KF, Burk RD (1991) Human papillomavirus infection and other risk factors for cervical neoplasia: a case-control study. Int J Cancer 49:6-13
26. Nickoloff BJ, Turka LA (1994) Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes. Immunol Today 15:464-469
27. Nickoloff BJ, Mitra RS, Green J, Zheng XG, Shimizu Y, Thompson C, Turka LA (1993) Accessory cell function of keratinocytes for superantigens. Dependence on lymphocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction. J Immunol 150:2148-2159
28. Pamer EG, Harty JT, Bevan MJ (1991) Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes. Nature 353:852-855
29. Parkin DM, Stjernsward J, Muir CS (1984) Estimates of the worldwide frequency of twelve major cancers. Bull World Health Organ 62:163-182
30. Petry KU, Scheffel D, Bode U, Gabrysiak T, Kochel H, Kupsch E, Glaubitz M, Niesen S, Kuhnle H, Schedel I (1994) Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions. Int J Cancer 57:836-840
31. Reeves WC, Brinton LA, Garcia M, Brenes MM, Herrero R, Gaitan E, Tenorio F, Britton RC de, Rawls WE (1989) Human papillomavirus infection and cervical cancer in Latin America. N Engl J Med 320:1437-1441
32. Ressing ME, Sette A, Brandt RM, Ruppert J, Wentworth PA, Hartman M, Oseroff C, Grey HM, Melief CJ, Kast WM (1995) Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides. J Immunol 154:5934-5943
33. Riddell SR, Greenberg PD (1990) The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells. J Immunol Methods 128:189-201
34. Roscoe DM, Ishikawa K, Lyles DS (1991) Role of de novo protein synthesis in target cells recognized by cytotoxic T lymphocytes specific for vesicular stomatitis virus. J Virol 65:6856-6861
35. Rotzschke O, Falk K, Stevanovic S, Jung G, Waiden P, Rammensee HG (1991) Exact prediction of a natural T cell epitope. Eur J Immunol 21:2891-2894
36. Sadovnikova E, Zhu X, Collins SM, Zhou J, Vousden K, Crawford L, Beverley P, Stauss HJ (1994) Limitations of predictive motifs revealed by cytotoxic T lymphocyte epitope mapping of the human papilloma virus E7 protein. Int Immunol 6:289-296
37. Sanger FS, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463-5468
38. Scheffner M, Munger K, Huibregtse JM, Howley PM (1992) Targeted degradation of the retinoblastoma protein by human papillomavirus E7-E6 fusion proteins. EMBO J 11:2425-2431
39. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, Scott DR, Sherman ME, Kurman RJ, Wacholder S, et al (1993) Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 85:958-964
40. Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A, Zur Hausen H (1985) Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314:111-114
41. Spiro RC, Freeze HH, Sampath D, Garcia JA (1991) Uncoupling of chondroitin sulfate glycosaminoglycan synthesis by brefeldin A. J Cell Biol 115:1463-1473
42. Tarpey I, Stacey S, Hickling J, Birley HD, Renton A, McIndoe A, Davies DH (1994) Human cytotoxic T lymphocytes stimulated by endogenously processed human papilliomavirus type 11 E7 recognize a peptide containing a HLA-A2 (A*0201) motif. Immunology 81:222-227
43. Tiwari JL, Terasaki PI (1985) The HLA complex. In: Tiwari JL, Terasaki PI (eds) HLA and disease associations. Springer, New York Berlin Heidelberg, pp 4-17
44. Townsend A, Bodmer H (1989) Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol 7:601-624
45. Von Knebel Doeberitz M, Bauknecht T, Bartsch D, Zur Hausen H (1991) Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells. Proc Natl Acad Sci USA 88:1411-1415
46. Von Knebel Doeberitz M, Oltersdorf T, Schwarz E, Gissmann L (1988) Correlation of modified human pupilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. Cancer Res 48:3780-3786
47. Yee C, Krishnan Hewlett I, Baker CC, Schlegel R, Howley PM (1985) Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol 119:361-366
48. Zur Hausen H (1991) Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184:9-13